|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0023981,
umls-concept:C0079731,
umls-concept:C0205195,
umls-concept:C0242602,
umls-concept:C0393022,
umls-concept:C0439859,
umls-concept:C0580822,
umls-concept:C1096776,
umls-concept:C1328050,
umls-concept:C1547300,
umls-concept:C1548760,
umls-concept:C1550594
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2009-12-21
|
|
pubmed:abstractText |
To investigate the feasibility and efficacy of rituximab combined with high-dose chemotherapy supported by autologous peripheral blood stem cell transplantation (ASCT) in patients with aggressive B-cell non-Hodgkin lymphoma (NHL).
|
|
pubmed:language |
chi
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal...,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide,
http://linkedlifedata.com/resource/pubmed/chemical/Dexamethasone,
http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin,
http://linkedlifedata.com/resource/pubmed/chemical/Etoposide,
http://linkedlifedata.com/resource/pubmed/chemical/Ifosfamide,
http://linkedlifedata.com/resource/pubmed/chemical/Prednisolone,
http://linkedlifedata.com/resource/pubmed/chemical/Prednisone,
http://linkedlifedata.com/resource/pubmed/chemical/Vincristine,
http://linkedlifedata.com/resource/pubmed/chemical/rituximab
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0253-3766
|
|
pubmed:author |
pubmed-author:CenXi-nanXN,
pubmed-author:ChenHuH,
pubmed-author:HanMing-zheMZ,
pubmed-author:HanXiao-hongXH,
pubmed-author:HeXiao-huiXH,
pubmed-author:HuangHeH,
pubmed-author:HuangHui-qiangHQ,
pubmed-author:JiangWen-qiWQ,
pubmed-author:LiuPengP,
pubmed-author:NEWWW,
pubmed-author:RenHan-yunHY,
pubmed-author:ShiYuan-kaiYK,
pubmed-author:ThuomasK AKA,
pubmed-author:WangChunC,
pubmed-author:WangJian-mingJM,
pubmed-author:YangShengS,
pubmed-author:ZhouShu-yunSY,
pubmed-author:ZhuJunJ
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
31
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
592-6
|
|
pubmed:meshHeading |
pubmed-meshheading:20021946-Adolescent,
pubmed-meshheading:20021946-Adult,
pubmed-meshheading:20021946-Antibodies, Monoclonal, Murine-Derived,
pubmed-meshheading:20021946-Antineoplastic Agents,
pubmed-meshheading:20021946-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:20021946-Cisplatin,
pubmed-meshheading:20021946-Combined Modality Therapy,
pubmed-meshheading:20021946-Cyclophosphamide,
pubmed-meshheading:20021946-Dexamethasone,
pubmed-meshheading:20021946-Disease-Free Survival,
pubmed-meshheading:20021946-Doxorubicin,
pubmed-meshheading:20021946-Etoposide,
pubmed-meshheading:20021946-Female,
pubmed-meshheading:20021946-Fever,
pubmed-meshheading:20021946-Humans,
pubmed-meshheading:20021946-Ifosfamide,
pubmed-meshheading:20021946-Lymphoma, Large B-Cell, Diffuse,
pubmed-meshheading:20021946-Male,
pubmed-meshheading:20021946-Middle Aged,
pubmed-meshheading:20021946-Peripheral Blood Stem Cell Transplantation,
pubmed-meshheading:20021946-Prednisolone,
pubmed-meshheading:20021946-Prednisone,
pubmed-meshheading:20021946-Prospective Studies,
pubmed-meshheading:20021946-Remission Induction,
pubmed-meshheading:20021946-Survival Rate,
pubmed-meshheading:20021946-Vincristine,
pubmed-meshheading:20021946-Vomiting,
pubmed-meshheading:20021946-Young Adult
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
[A prospective multicenter study of rituximab combined with high-dose chemotherapy and autologous peripheral blood stem cell transplantation for aggressive B-cell lymphoma].
|
|
pubmed:affiliation |
Department of Medical Oncology, Cancer Hospital (Institute), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China. Syuankai@yahoo.com.cn
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
English Abstract,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
